116 related articles for article (PubMed ID: 31911031)
1. Evaluation of the protective efficacy of recombinant protective antigen vaccine (GC1109)-immunized human sera using passive immunization in a mouse model.
Jo SK; Ahn BE; Choi EH; Kang JE; An H; Oh MD; Rhie GE
Vaccine; 2020 Feb; 38(7):1586-1588. PubMed ID: 31911031
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and Protective Efficacy of Recombinant Protective Antigen Anthrax Vaccine (GC1109) in A/J Mice Model.
Kim GL; Pyo SW; Yi H; Kim SH; Shin H; Yu MA; Hwang YR; Choi SY; Jeon JH; Jo SK; Rhie GE
Vaccine; 2023 May; 41(19):3106-3110. PubMed ID: 37055344
[TBL] [Abstract][Full Text] [Related]
3. Use of the mice passive protection test to evaluate the humoral response in goats vaccinated with Sterne 34F2 live spore vaccine.
Phaswana PH; Ndumnego OC; Koehler SM; Beyer W; Crafford JE; van Heerden H
Vet Res; 2017 Sep; 48(1):46. PubMed ID: 28882176
[TBL] [Abstract][Full Text] [Related]
4. BA3338, a surface layer homology domain possessing protein augments immune response and protection efficacy of protective antigen against Bacillus anthracis in mouse model.
Kumar M; Puranik N; Varshney A; Tripathi N; Pal V; Goel AK
J Appl Microbiol; 2020 Aug; 129(2):443-452. PubMed ID: 32118336
[TBL] [Abstract][Full Text] [Related]
5. Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine.
Zeng M; Xu Q; Pichichero ME
Vaccine; 2007 May; 25(18):3588-94. PubMed ID: 17293013
[TBL] [Abstract][Full Text] [Related]
6. Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen.
Peachman KK; Rao M; Alving CR; Burge R; Leppla SH; Rao VB; Matyas GR
Infect Immun; 2006 Jan; 74(1):794-7. PubMed ID: 16369043
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model.
Ndumnego OC; Köhler SM; Crafford J; van Heerden H; Beyer W
Vet Immunol Immunopathol; 2016 Oct; 178():14-21. PubMed ID: 27496738
[TBL] [Abstract][Full Text] [Related]
8. Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization.
Herrmann JE; Wang S; Zhang C; Panchal RG; Bavari S; Lyons CR; Lovchik JA; Golding B; Shiloach J; Lu S
Vaccine; 2006 Jul; 24(31-32):5872-80. PubMed ID: 16790303
[TBL] [Abstract][Full Text] [Related]
9. Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model.
Suryanarayana N; Verma M; Thavachelvam K; Saxena N; Mankere B; Tuteja U; Hmuaka V
Appl Microbiol Biotechnol; 2016 Oct; 100(19):8439-51. PubMed ID: 27364624
[TBL] [Abstract][Full Text] [Related]
10. Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin.
Gaur R; Gupta PK; Banerjea AC; Singh Y
Vaccine; 2002 Jun; 20(21-22):2836-9. PubMed ID: 12034111
[TBL] [Abstract][Full Text] [Related]
11. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
[TBL] [Abstract][Full Text] [Related]
12. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
Welkos S; Little S; Friedlander A; Fritz D; Fellows P
Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
[TBL] [Abstract][Full Text] [Related]
13. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
[TBL] [Abstract][Full Text] [Related]
14. Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine.
Little SF; Ivins BE; Webster WM; Fellows PF; Pitt ML; Norris SL; Andrews GP
Vaccine; 2006 Mar; 24(14):2530-6. PubMed ID: 16417950
[TBL] [Abstract][Full Text] [Related]
15. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.
Lee DY; Chun JH; Ha HJ; Park J; Kim BS; Oh HB; Rhie GE
FEMS Immunol Med Microbiol; 2009 Nov; 57(2):165-72. PubMed ID: 19732139
[TBL] [Abstract][Full Text] [Related]
16. Induction of protective immunity against lethal anthrax challenge with a patch.
Kenney RT; Yu J; Guebre-Xabier M; Frech SA; Lambert A; Heller BA; Ellingsworth LR; Eyles JE; Williamson ED; Glenn GM
J Infect Dis; 2004 Aug; 190(4):774-82. PubMed ID: 15272406
[TBL] [Abstract][Full Text] [Related]
17. Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge.
Huang J; Mikszta JA; Ferriter MS; Jiang G; Harvey NG; Dyas B; Roy CJ; Ulrich RG; Sullivan VJ
Hum Vaccin; 2007; 3(3):90-3. PubMed ID: 17375001
[TBL] [Abstract][Full Text] [Related]
18. Bacillus anthracis Capsular Conjugates Elicit Chimpanzee Polyclonal Antibodies That Protect Mice from Pulmonary Anthrax.
Chen Z; Schneerson R; Lovchik JA; Dai Z; Kubler-Kielb J; Agulto L; Leppla SH; Purcell RH
Clin Vaccine Immunol; 2015 Aug; 22(8):902-8. PubMed ID: 26041039
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax.
Williamson ED; Hodgson I; Walker NJ; Topping AW; Duchars MG; Mott JM; Estep J; Lebutt C; Flick-Smith HC; Jones HE; Li H; Quinn CP
Infect Immun; 2005 Sep; 73(9):5978-87. PubMed ID: 16113318
[TBL] [Abstract][Full Text] [Related]
20. Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization.
Li H; Soroka SD; Taylor TH; Stamey KL; Stinson KW; Freeman AE; Abramson DR; Desai R; Cronin LX; Oxford JW; Caba J; Pleatman C; Pathak S; Schmidt DS; Semenova VA; Martin SK; Wilkins PP; Quinn CP
J Immunol Methods; 2008 Apr; 333(1-2):89-106. PubMed ID: 18304568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
